CytoDyn (CYDY) Interest Expenses (2012 - 2026)

CytoDyn (CYDY) has 17 years of Interest Expenses data on file, last reported at $1.8 million in Q1 2026.

• Quarterly Interest Expenses rose 56.96% year-over-year to $1.8 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $1.8 million (down 97.0% YoY) and the FY2025 annual result came in at $126.2 million, up 110.68% from the prior year.
• Interest Expenses declined to $1.8 million in Q1 2026, from $3.8 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $56.4 million in Q2 2024 to a low of -$24.4 million in Q2 2023.
• A 5-year average of $7.4 million and a median of $3.0 million in 2025 frame the typical range for Interest Expenses.
• Annual changes were most pronounced in 2023 — Interest Expenses plunged 555.23% — and 2024, when it surged 331.35%.
• Tracing CYDY's Interest Expenses over 5 years: stood at $3.3 million in 2022, then plunged by 65.07% to $1.2 million in 2023, then retreated by 0.26% to $1.2 million in 2024, then soared by 226.53% to $3.8 million in 2025, then sank by 52.68% to $1.8 million in 2026.
• The last three Interest Expenses figures came in at $1.8 million (Q1 2026), $3.8 million (Q4 2025), and $3.0 million (Q3 2025), per Business Quant data.